# US 2015/0273751 A1 · Bioactive composites of polymer and glass and method for making same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0273751 A1
- Document ID: US20150273751A1
- Status: Published application
- Kind: A1
- Application number: 14/699,333
- Filed: 2015-04-29
- Published: 2015-10-01
- Earliest claimed: 2008-12-30
- Assignees: Orthovita, Inc.
- Applicants: Orthovita, Inc.
- Inventors: Theodore D. Clineff; Marissa M. Conrad; Matthew B. Havener; James P. Murphy; Zachary S. Szczerbinski
- Web page: https://patentgrep.com/patent/US20150273751A1

## CPC

- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61B 17/742: {having one or more longitudinal elements oriented along or parallel to the axis of the neck}
- A61B 17/80: Cortical plates {, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates}
- A61B 17/86: Pins or screws {or threaded wires; nuts therefor (A61B17/72 take precedence)}
- A61C 8/0012: {characterised by the material or composition, e.g. ceramics, surface layer, metal alloy (use of specific materials A61K6/00)}
- A61C 8/0016: {polymeric material}
- A61F 2/28: Bones
- A61F 2/2803: {for mandibular reconstruction (temporo-mandibular joints A61F2/3099; bone plates for the jaw A61B17/8071)}
- A61F 2/2875: {Skull or cranium (A61F2/2803 takes precedence; joints for temporo-mandibular [TM] joints [TMJ] A61F2/3099)}
- A61F 2/30734: {Modular inserts, sleeves or augments, e.g. placed on proximal part of stem for fixation purposes or wedges for bridging a bone defect}
- A61F 2/30771: {applied in original prostheses, e.g. holes or grooves}
- A61F 2/32: for the hip
- A61F 2/4455: {for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages (intervertebral discs A61F2/442)}
- A61F 2/446: {having a circular or elliptical cross-section substantially parallel to the axis of the spine, e.g. cylinders or frustocones}
- A61F 2/4465: {having a circular or kidney shaped cross-section substantially perpendicular to the axis of the spine}
- A61F 2/447: {substantially parallelepipedal, e.g. having a rectangular or trapezoidal cross-section}
- A61F 2/4611: {of spinal prostheses}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 31/128: {containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127}
- B29C 48/022: {characterised by the choice of material}
- B29C 48/288: {in solid form, e.g. powder or granules}
- B29C 48/832: {Heating}
- C08K 3/40: Glass
- A61F 2002/2882: {Malar or zygomatic implants}
- A61F 2002/30062: {(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive}
- A61F 2002/30131: {horseshoe- or crescent- or C-shaped or U-shaped}
- A61F 2002/30593: {hollow}
- A61F 2002/30738: {Sleeves}
- A61F 2002/30787: {inclined obliquely with respect to each other}
- A61F 2002/3082: {Grooves}
- A61F 2002/30828: {parallel}
- A61F 2002/3085: {with a threaded, e.g. self-tapping, bone-engaging surface, e.g. external surface}
- A61F 2002/30892: {parallel}
- A61F 2002/448: {comprising multiple adjacent spinal implants within the same intervertebral space or within the same vertebra, e.g. comprising two adjacent spinal implants}
- A61F 2002/4622: {having the shape of a forceps or a clamp}
- A61F 2002/4631: {the prosthesis being specially adapted for being cemented}
- A61F 2002/4681: {by applying mechanical shocks, e.g. by hammering}
- A61F 2210/0004: bioabsorbable
- A61F 2230/0013: Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
- A61F 2310/00329: Glasses, e.g. bioglass
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/38: for reconstruction of the spine, vertebrae or intervertebral discs
- B29B 9/06: in the form of filamentary material, e.g. combined with extrusion
- B29B 9/12: characterised by structure or composition
- B29C 45/0001: {characterised by the choice of material}
- B29K 2071/00: Use of polyethers {, e.g. PEEK, i.e. polyether-etherketone or PEK, i.e. polyetherketone or derivatives thereof}, as moulding material
- B29K 2105/126: {Whiskers, i.e. reinforcement in the form of monocrystals}
- B29K 2105/16: Fillers
- B29K 2509/08: Glass
- B29K 2995/0056: Biocompatible, e.g. biopolymers or bioelastomers
- B29L 2031/7532: {Artificial members, protheses}
- C08G 2650/40: containing ketone groups, e.g. polyarylethylketones, PEEK or PEK
- C08K 2201/005: Additives being defined by their particle size in general
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61C: DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE (non-driven toothbrushes A46B; {tongue scrapers A61B17/24;} preparations for dentistry A61K6/00; preparations for cleaning the teeth or mouth A61K8/00, A61Q11/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- B29B: PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

The present invention relates to a method of preparing a bioactive composite, the method comprising the steps of a) adding in a solid state a biocompatible polymer and a bioactive glass to an extruder to form an extrudable material; b) applying energy to the extrudable material to at least the melting temperature of the biocompatible polymer to melt mix the biocompatible polymer and bioactive glass; and c) extruding a bioactive composite.

## Claims

### Claim 1

A method of preparing a bioactive composite, comprising:
a) heating polyaryletherketone polymer particles to at least the melting temperature of the polyaryletherketone polymer to at least partially melt the polyaryletherketone polymer particles, wherein the polyaryetherketone polymer particles have a particle size ranging from 400 μm to 4,000 μm prior to heating, and wherein the polyaryletherketone polymer has a molecular weight ranging from 70,000 to 120,000 Daltons prior to heating;
b) adding alkali-containing bioactive glass particles to the at least partially melted polyaryletherketone particles,
wherein the alkali-containing bioactive glass particles have a particle size ranging from 1 μm to 500 μm; and
c) extruding a bioactive composite, wherein the polyaryletherketone polymer is present in an amount of 70% to 85% by weight of the extruded bioactive composite, and wherein the alkali-containing bioactive glass particles is present in an amount of 15% to 30% by weight of the extruded bioactive composite.

### Claim 2 (depends on 1)

The method of claim 1, wherein prior to adding the alkali-containing bioactive glass particles, further comprising:
mixing the at least partially melted polyaryletherketone polymer particles.

### Claim 3 (depends on 1)

The method of claim 1, wherein the polyaryletherketone polymer is polyetheretherketone (PEEK).

### Claim 4 (depends on 3)

The method of claim 3, wherein the PEEK polymer is present in an amount of 70% to 80% by weight of the extruded bioactive composite, and wherein the alkali-containing bioactive glass particles is present in an amount of 20% to 30% by weight of the extruded bioactive composite

### Claim 5 (depends on 1)

The method of claim 1, wherein the polyaryletherketone polymer has a size range from 1000 μm to 4000 μm.

### Claim 6 (depends on 1)

The method of claim 1, wherein the alkali-containing bioactive glass particles are 45S5 or Combeite glass-ceramic.

### Claim 7 (depends on 1)

The method of claim 1, wherein the alkali-containing bioactive glass particles have a particle size range from 50 μm to 250 μm.

### Claim 8 (depends on 1)

The method of claim 1, wherein the composite is non-resorbable.

### Claim 9 (depends on 1)

The method of claim 1, wherein the amount by weight of the alkali-containing bioactive glass particles in the extruded bioactive composite, measured in a plurality of samples taken from the composite, has a standard deviation ranging from 0.10 to 0.33.

### Claim 10

A method of preparing a homogeneous bioactive shaped body, comprising:
a) heating polyaryletherketone polymer particles to at least the melting temperature of the polyaryletherketone polymer to at least partially melt the polyaryletherketone polymer particles, wherein the polyaryetherketone polymer particles have a particle size ranging from 400 μm to 4,000 μm prior to heating, and wherein the polyaryletherketone polymer has a molecular weight ranging from 70,000 to 120,000 Daltons prior to heating;
b) adding alkali-containing bioactive glass particles to the at least partially melted polyaryletherketone polymer particles, wherein the alkali-containing bioactive glass particles have a particle size ranging from 1 μm to 500 μm; and
c) extruding homogeneous pellets of polyaryletherketone polymer and alkali-containing bioactive glass particles, wherein the polyaryletherketone polymer is present in an amount of 70% to 80% by weight of the homogeneous pellets, and wherein the alkali-containing bioactive glass particles are present in an amount of 20% to 30% by weight of the homogeneous pellets; and
d) injection molding the homogeneous pellets to form the homogeneous bioactive shaped body.

### Claim 11 (depends on 10)

The method of claim 10, wherein prior to adding the alkali-containing bioactive glass particles, further comprising:
mixing the at least partially melted polyaryletherketone polymer particles.

### Claim 12 (depends on 10)

The shaped body of claim 10, wherein the polyaryletherketone polymer is polyetheretherketone (PEEK).

### Claim 13 (depends on 12)

The shaped body of claim 12, wherein the alkali-containing bioactive glass particles has a particle size range from 50 μm to 250 μm.

### Claim 14 (depends on 10)

The method of claim 10, wherein the polyaryletherketone polymer has a size range from 1000 μm to 4000 μm.

### Claim 15 (depends on 10)

The method of claim 10, wherein the alkali-containing bioactive glass particles are 45S5 or Combeite glass-ceramic.

### Claim 16 (depends on 10)

The method of claim 10, wherein the composite is non-resorbable.

### Claim 17

A method of preparing a bioactive composite, comprising:
a) heating polyetheretherketone (PEEK) polymer particles to at least the melting temperature of the PEEK polymer to at least partially melt the PEEK polymer particles, wherein the PEEK polymer particles have a particle size ranging from 400 μm to 4,000 μm prior to heating, and wherein the PEEK polymer has a molecular weight ranging from 100,000 to 120,000 Daltons prior to heating;
b) adding alkali-containing bioactive glass particles to the at least partially melted PEEK polymer particles, wherein the bioactive glass particles have a particle size range from 1 μm to 500 μm; and
c) extruding a bioactive composite, wherein the PEEK polymer is present in an amount of 70% to 80% by weight of the extruded bioactive composite, and wherein the alkali-containing bioactive glass particles is present in an amount of 20% to 30% by weight of the extruded bioactive composite.

### Claim 18 (depends on 17)

The method of claim 17, wherein prior to adding the alkali-containing bioactive glass particles, further comprising:
mixing the at least partially melted PEEK polymer particles.
